UBS Group Portfolio holdings
UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Strategy Inc
MSTR
|
+$1.21B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$855M |
| 3 |
Microsoft
MSFT
|
+$810M |
| 4 |
Advanced Micro Devices
AMD
|
+$805M |
| 5 |
Boeing
BA
|
+$739M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
UnitedHealth
UNH
|
+$561M |
| 2 |
Amneal Pharmaceuticals
AMRX
|
+$169M |
| 3 |
Eli Lilly
LLY
|
+$161M |
| 4 |
Unity
U
|
+$158M |
| 5 |
State Street SPDR S&P Regional Banking ETF
KRE
|
+$127M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.49% |
| 2 | Financials | 9.06% |
| 3 | Consumer Discretionary | 7.01% |
| 4 | Healthcare | 6.25% |
| 5 | Industrials | 6.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
BELFB
5276
Bel Fuse Inc Class B
BELFB
$4.21B
| $1.02M | ﹤0.01% |
12,328
+4,929
| +67% | +$399K |
|
5277
Cohen & Steers Real Estate Opportunities and Income Fund
RLTY
$265M
| $1.02M | ﹤0.01% |
68,763
+56,312
| +452% | +$906K |
|
5278
BNY Mellon Core Bond ETF
BKAG
$2.23B
| $1.01M | ﹤0.01% |
24,592
+1,487
| +6% | +$62.4K |
|
|
PMM
5279
Franklin Managed Municipal Income Trust
PMM
$273M
| $1.01M | ﹤0.01% |
169,720
+7,766
| +5% | +$48.8K |
|
5280
MicroSectors FANG+ Index -3X Inverse Leveraged ETNs due January 8, 2038
FNGD
$319M
| $1.01M | ﹤0.01% |
7,413
+7,183
| +3,123% | +$1.22M |
|
5281
PUT
Domo
DOMO
$184M
| $1.01M | ﹤0.01% |
+143,000
| New | +$1.16M |
|
|
CEPU
5282
Central Puerto
CEPU
$2.1B
| $1.01M | ﹤0.01% |
69,639
+61,301
| +735% | +$765K |
|
5283
Palladyne AI
PDYN
$296M
| $1.01M | ﹤0.01% |
82,119
+81,862
| +31,853% | +$286K |
|
|
SEZL
5284
Sezzle
SEZL
$3.97B
| $1.01M | ﹤0.01% |
23,622
+17,010
| +257% | +$804K |
|
5285
Quad
QUAD
$525M
| $1.01M | ﹤0.01% |
144,276
+128,154
| +795% | +$868K |
|
|
LSEA
5286
DELISTED
Landsea Homes
LSEA
| $1.01M | ﹤0.01% |
118,388
+63,362
| +115% | +$683K |
|
|
GOOS
5287
CALL
Canada Goose Holdings
GOOS
$856M
| $1M | ﹤0.01% |
100,000
| – | – |
|
5288
Invesco Global Listed Private Equity ETF
PSP
$246M
| $1M | ﹤0.01% |
15,005
-5,843
| -28% | -$402K |
|
|
OPPJ
5289
WisdomTree Trust WisdomTree Japan Opportunities Fund
OPPJ
$284M
| $993K | ﹤0.01% |
28,726
+24,297
| +549% | +$835K |
|
5290
PIMCO Corporate & Income Opportunity Fund
PTY
$2.51B
| $993K | ﹤0.01% |
69,091
-4,190
| -6% | -$60.9K |
|
5291
El Pollo Loco
LOCO
$462M
| $992K | ﹤0.01% |
85,967
+12,572
| +17% | +$158K |
|
5292
Cabaletta Bio
CABA
$455M
| $986K | ﹤0.01% |
434,557
+411,783
| +1,808% | +$1.45M |
|
5293
AXT Inc
AXTI
$5.8B
| $986K | ﹤0.01% |
454,224
+393,352
| +646% | +$893K |
|
5294
CALL
Nice
NICE
$5.97B
| $985K | ﹤0.01% |
5,800
-66,165
| -92% | -$11.8M |
|
|
GOOS
5295
Canada Goose Holdings
GOOS
$856M
| $985K | ﹤0.01% |
98,201
+67,021
| +215% | +$684K |
|
5296
Blend Labs
BLND
$386M
| $985K | ﹤0.01% |
233,901
+102,331
| +78% | +$440K |
|
5297
CALL
Structure Therapeutics
GPCR
$3.78B
| $984K | ﹤0.01% |
+36,300
| New | +$1.29M |
|
|
GRRR
5298
Gorilla Technology Group
GRRR
$365M
| $981K | ﹤0.01% |
+54,309
| New | +$357K |
|
5299
iShares Currency Hedged MSCI Emerging Markets
HEEM
$288M
| $979K | ﹤0.01% |
36,233
-6,693
| -16% | -$188K |
|
5300
Coherus Oncology
CHRS
$196M
| $978K | ﹤0.01% |
708,999
+535,830
| +309% | +$601K |
|
Similar funds
UBS Group's Q4 2024 Portfolio in Review
As of Q4 2024, UBS Group held 10,816 positions worth $541B, up 18% from $459B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
UBS Group deployed $80.6B of net new capital in Q4 2024, opening 1,382 new positions and adding to 6,044 existing holdings. Its largest new stake was Primo Brands: 1,234,826 shares worth $38M.
By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 17% a quarter earlier, followed by Financials and Consumer Discretionary.
On the sell side, the largest reduction was UnitedHealth, an estimated $561M trimmed.
- UBS Group's largest Q4 2024 buy was Primo Brands: 1,234,826 shares worth $38M.
- UBS Group added most to Strategy Inc in Q4 2024, an estimated $1.21B increase.
- UBS Group's biggest Q4 2024 reduction was UnitedHealth, cutting an estimated $561M.
- UBS Group fully exited CATALENT, INC. in Q4 2024, selling an estimated $86M.
- UBS Group's ten largest holdings make up 16% of its $541B portfolio in Q4 2024.
- UBS Group opened 1,382 new positions and closed 943 in Q4 2024.
- UBS Group's portfolio value rose 18% quarter-over-quarter to $541B.
Based on UBS Group's 13F filing for Q4 2024, filed 14 Feb 2025.